Johnson & Johnson (JNJ) Stock Price & AI Analysis

NYSE
USA

$149.31

$1
(1.49%)

Subscribe to get
AI Score

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson | Latest news

Johnson & Johnson (NYSE:JNJ) Stock Acquired Rep. Josh Gottheimer

Representative Josh Gottheimer (D-New Jersey) recently bought shares of Johnson & Johnson (NYSE:JNJ). In a filing disclosed on December 05th, the Representative disclosed that they had bought ...

ETF DAILY NEWS - 13 hours ago

Is Johnson & Johnson (JNJ) Dominating A Billionaire Quant’s Investment Strategy...

We recently compiled a list of the 10 Stocks Dominating a Billionaire Quant’s Investment Strategy....

Insider Monkey - 23 hours ago

Why Is Johnson & Johnson (JNJ) Among the Dividend Kings You Should Consider?

We recently compiled a list of the Dividend Kings List: Top 15. In this article, we are going to...

Insider Monkey - 4 days ago

Why Is Johnson & Johnson (JNJ) Among the Stocks Ray Dalio’s Bridgewater Is Crazy...

We recently compiled a list of the Billionaire Ray Dalio’s Bridgewater Is Crazy About These 15...

Insider Monkey - 6 days ago

Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You...

The most recent trading session ended with Johnson & Johnson (JNJ) standing at $150.47, reflecting a...

Zacks - 4 days ago

J&J baby powder lawsuits stay paused amid bankruptcy trial plans By...

Litigation alleging that Johnson & Johnson (NYSE:JNJ)'s baby powder is linked to ovarian cancer will...

Investingcom - 6 days ago

Should You Invest in Johnson & Johnson

Johnson & Johnson (NYSE: JNJ) has a higher price-to-earnings ratio of 25.59x compared to its average ratio, The 36-month beta value for JNJ is at 0.50. 3 Tiny Stocks Primed to Explode The world's ...

NewsHeater - 5 days ago

Johnson & Johnson (NYSE:JNJ) Shares Sold by Dynamic Technology Lab Private Ltd

Dynamic Technology Lab Private Ltd reduced its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 79.5% during the 3rd quarter, Holdings Channel reports. The fund owned 1,703 shares of ...

ETF DAILY NEWS - 7 days ago

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth...

Zacks - 6 days ago

J&J Seeks FDA Approval for Tremfya for Psoriasis in Kids

Johnson & Johnson JNJ announced that it has filed two supplemental biologics license applications...

Zacks - 5 days ago